Dr. Simonton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 Blythe Blvd
Ste 300
Charlotte, NC 28203Phone+1 704-373-0212Fax+1 704-373-1216
Summary
- I am a board-certified interventional cardiologist and previously in private practice at the Sanger Clinic and Carolinas Medical Center in Charlotte, NC for 20 years. During that time I founded the Carolinas Cardiovascular Foundation and the interventional cardiology research program, as well as performing over 500 coronary interventions per year. I then transitioned in 2007 to the position of Chief Medical Officer and Divisional Vice President, Abbott Vascular, a division of Abbott, located in Santa Clara, California.
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 1984 - 1986
- University of California (San Francisco)Residency, Internal Medicine, 1980 - 1984
- Harvard Medical SchoolClass of 1980
Certifications & Licensure
- CA State Medical License 1982 - Present
- NC State Medical License 1984 - 2024
- SC State Medical License 1989 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 79 citationsImplications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.John Gregson, Gregg W. Stone, Ori Ben-Yehuda, Björn Redfors, David E. Kandzari
Journal of the American College of Cardiology. 2020-10-06 - 180 citations3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III TrialDean J. Kereiakes, Stephen G. Ellis, Christopher Metzger, Ronald P. Caputo, David G. Rizik
Journal of the American College of Cardiology. 2017-12-12 - 473 citationsEverolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G. Ellis, Dean J. Kereiakes, D. Christopher Metzger, Ronald P. Caputo, David G. Rizik
The New England Journal of Medicine. 2015-11-11
Journal Articles
- Original Investigation Left Main Revascularization with PCI or CABG in Patients with Chronic Kidney Disease: EXCEL TrialJohn D Puskas, David E Kandzari, Gennaro Giustino, Roxana Mehran, Martin B Leon, Philippe Genereux, Michael 3rd Ragosta, Charles A Simonton, Irving L Kron, Gregg W Stone, ScienceDirect
- Focus on Left Main Interventions Outcomes After Coronary Stenting or Bypass Surgery for Men and Women with Unprotected Left Main Disease: The EXCEL TrialNicholas J Lembo, Gregg W Stone, Charles A Simonton, ScienceDirect
Press Mentions
- Abbott Leads Way in First Clinical Trial of Minimally Invasive Clip-Based Repair System for Leaky Tricuspid Heart ValvesAugust 10th, 2017
- The Ups and Downs of the Latest Absorb DataMarch 20th, 2017
- FDA Warns of Increased Major Adverse Cardiac Events with the Absorb Dissolving StentMarch 20th, 2017
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Industry Relationships
- Chief Medical Officer and Divisional Vice President, Abbott Vascular2007 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: